Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 49.46% institutional investors, 24.66% insiders, and 25.88% retail investors. Fmr is the largest institutional shareholder, holding 8.93% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.81% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Roivant Sciences | 49.46% | 24.66% | 25.88% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 60.77M | 8.93% | $919.40M |
| Morgan stanley | 58.36M | 8.37% | $1.27B |
| Vanguard group | 42.06M | 6.18% | $912.68M |
| Sb investment advisers (uk) | 40.32M | 5.93% | $609.97M |
| Blackrock funding, inc. /de | 41.17M | 5.91% | $893.40M |
| Blackrock | 35.37M | 4.41% | $373.86M |
| Qvt financial lp | 29.38M | 4.32% | $444.54M |
| Viking global investors lp | 23.59M | 3.47% | $356.99M |
| State street | 18.70M | 2.75% | $282.93M |
| Ubs group | 18.39M | 2.70% | $399.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
| Patient square capital lp | 8.17M | 37.93% | $177.20M |
| Qvt financial lp | 29.38M | 31.37% | $444.54M |
| Whitefort capital management, lp | 3.53M | 15.79% | $53.44M |
| Stempoint capital lp | 4.20M | 12.72% | $63.50M |
| Cutter capital management, lp | 1.30M | 5.71% | $13.12M |
| Blackbarn capital partners lp | 4.40M | 4.76% | $66.57M |
| Adar1 capital management | 3.35M | 4.76% | $50.65M |
| Sb investment advisers (uk) | 40.32M | 4.60% | $609.97M |
| Two seas capital lp | 9.79M | 4.38% | $212.48M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 18.39M | 0.06% | 15.65M |
| Morgan stanley | 58.36M | 0.08% | 14.04M |
| Goldman sachs group | 10.98M | 0.03% | 8.62M |
| Assenagon asset management | 6.94M | 0.21% | 6.88M |
| Fmr | 60.77M | 0.05% | 5.26M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sb investment advisers (uk) | 40.32M | 4.60% | -19.64M |
| Rubric capital management lp | 9.00M | 2.34% | -11.00M |
| Viking global investors lp | 23.59M | 0.93% | -10.64M |
| Anchorage capital group | - | - | -4.83M |
| Avoro capital advisors | - | - | -4.65M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 5.20M | 0.01% | 5.20M | $112.75M |
| Jefferies financial group | 3.51M | 0.39% | 3.51M | $76.27M |
| Jennison associates | 2.35M | 0.03% | 2.35M | $51.07M |
| Voloridge investment management | 2.28M | 0.12% | 2.28M | $34.51M |
| Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -2.00 |
| Stephens consulting | -3.00 |
| Northwestern mutual wealth management | -10.00 |
| Mather group, llc. | -13.00 |
| Cornerstone planning group | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 302 | -16.80% | 336,769,510 | -32.86% | 49 | 0.91% | 194 | 1.04% | 60 | -37.50% |
| Sep 30, 2025 | 297 | -14.41% | 349,519,827 | -24.94% | 51 | 1.19% | 157 | -11.80% | 81 | -23.58% |
| Jun 30, 2025 | 351 | 8.67% | 514,292,667 | -7.04% | 72 | 1.24% | 180 | 19.21% | 107 | 0.94% |
| Mar 31, 2025 | 15 | -95.41% | 102,194,746 | -81.83% | 14 | 0.23% | 6 | -96.18% | 3 | -97.12% |
| Dec 31, 2024 | 293 | -4.87% | 455,984,070 | -19.26% | 61 | 1.05% | 142 | -20.22% | 95 | 35.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 27.26M | 3.81% | 537.45K |
| Fidelity Growth Company Fund | 20.52M | 2.87% | 886.43K |
| Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
| Vanguard Total Stock Mkt Idx Inv | 14.41M | 2.01% | 35.67K |
| Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
| iShares Core S&P Mid-Cap ETF | 14.15M | 1.98% | 3.42M |
| Vanguard Small Cap Index | 10.24M | 1.43% | -782.00 |
| SPDR® S&P Biotech ETF | 7.21M | 1.06% | 16.07K |
| Morgan Stanley Inst Growth I | 6.37M | 0.89% | 1.09M |
| Morgan Stanley Growth SMA | 6.37M | 0.89% | 1.09M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Torti Frank | President and Vant Chair | Sell | $27.49M |
| Feb 23, 2026 | Torti Frank | President and Vant Chair | Sell | $16.16M |
| Feb 19, 2026 | Torti Frank | President and Vant Chair | Sell | $38.39M |
| Feb 13, 2026 | Venker Eric | President & Immunovant CEO | Sell | $5.30M |
| Feb 12, 2026 | MANCHESTER KEITH S | - | Sell | $4.01M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 21 |
| 2025 Q4 | - | 53 |
| 2025 Q3 | 1 | 9 |
| 2025 Q2 | - | 11 |
| 2025 Q1 | - | 7 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools